Ly49F (Klra6, Killer Cell Lectin-like Receptor, subfamily A, member 6, Killer Cell lectin-like receptor 6, Lymphocyte antigen 49f, T-cell surface glycoprotein Ly-49F)

591 EUR

500ug

GEN602171

N/A

N/A

N/A

N/A

N/A

5K30

Ly49F

IgG1,k

Purified

Antibodies

Monoclonal

cell, lymphocyte

Mnoclonal antibodies

Mouse (Mus musculus)

Mouse (Mus musculus)

Flow Cytometry (FC/FACS)

Supplied as a liquid in 100mM borate buffered saline, pH 8.2.

Mouse (Mus musculus); Due to limited knowledge and inability for testing each and every species, the reactivity of the antibody may extend to other species which are not listed hereby.

Store the antibody at +4 degrees Celsius for short term storage.. Aliquot to avoid repeated freezing and thawing. For optimal long term storage, the antibody should be kept at -20 degrees Celsius. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Recognizes the B6 allele of the mouse Ly49F receptor. Stains ~11% of NK1.1+CD3- splenocytes, and 3.5% (2.5 month-old) to 10.0% (11 month-old) of CD8+ spleen cells from C57BL/6 mice.; Since it is not possible to test each and every species our knowledge on the corss reactivity of the antibodies is limited. This particular antibody might cross react with speacies outside of the listed ones.

Antigens are peptides or recombinant or native dependent on the production method.For cells, cell lines and tissues in culture till half confluency.The receptors are ligand binding factors of type 1, 2 or 3 and protein-molecules that receive chemical-signals from outside a cell. When such chemical-signals couple or bind to a receptor, they cause some form of cellular/tissue-response, e.g. a change in the electrical-activity of a cell. In this sense, am olfactory receptor is a protein-molecule that recognizes and responds to endogenous-chemical signals, chemokinesor cytokines e.g. an acetylcholine-receptor recognizes and responds to its endogenous-ligand, acetylcholine. However, sometimes in pharmacology, the term is also used to include other proteins that are drug-targets, such as enzymes, transporters and ion-channels.